1. Bodiroga-Vukobrat N, Horak H (2016) Challenges of personalized medicine: socio-legal disputes and possible solutions. In: Bodiroga-Vukobrat N, Rukavina D, Pavelić K, Sander GG (eds) Personalized medicine: a new medical and social challenge. Springer, Basel, pp 31–51. ISBN 978-3-319-39347-6
2. Carlton DW, Perloff JM (2000) Modern industrial organization, 3rd edn. Addison Wesley Longman, Boston
3. Croatian Health Insurance Fund. Medication lists (June 2016). Available from:
http://www.hzzo.hr/zdravstveni-sustav-rh/trazilica-za-lijekove-s-vazecih-lista/arhiva-liste-lijekova/
4. Elek P, Takács E, Merész G, Kaló Z (2017) Implication of external price referencing and parallel trade on pharmaceutical expenditure: indirect evidence from lower-income European countries. Health Policy Plan 32(3):349–358
5. Garattini L, Curto A, Freemantle N (2016) Pharmaceutical price schemes in Europe: time for a ‘continental’ one? PharmacoEconomics 34:423–426